Skip to main content
. 2023 Apr 6;11(4):1110. doi: 10.3390/biomedicines11041110

Table 3.

Complications and mortality among NAFLD and non-NAFLD patients.

Variable NAFLD
211,955
Non-NAFLD Controls
452,012
p-Value
Cirrhosis 4429 (2.1) 4190 (0.9) <0.001
Age at cirrhosis, mean ± SD 64.8 ± 13 61.5 ± 12.3 <0.001
HCC 943 (0.44) 1586 (0.35) <0.001
Age of HCC 68.8 ± 11.9 67.1 ± 10.7 <0.001
Esophageal varices 1278 (0.6) 1136 (0.3) <0.001
Esophageal varices bleeding 647 (0.3) 678 (0.1) <0.001
SBP 303 (0.14) 314 (0.07) <0.001
Hepatorenal syndrome 284 (0.12) 276 (0.06) <0.001
Liver transplantation 194 (0.1) 272 (0.06) <0.001
Age at liver t transplantation, mean ± SD 55 ± 11.9 55.5 ± 10 0.656
Death 22,963 (10.8) 66,418 (14.7) <0.001
Age at death, mean ± SD 76.1 ± 12.3 71.4 ± 12.9 <0.001
Number of hospitalizations
From diagnosis, mean ± SD
4.3 ± 6.5 3.1 ± 5.6 <0.001

HCC—Hepatocellular Carcinoma; SBP—Spontaneous Bacterial Peritonitis.